GSK Korea announced on October 4th that it has appointed Maurizio Borgatta (pictured) as its new general manager.
Mr Maurizio Borgatta joined GSK in 2015 and has been recognized for his business leadership, employee-focused strategies and track record of driving growth across multiple disease area businesses.
He has successfully brought therapies and vaccines to European markets such as Belgium, Spain, Italy, and the United Kingdom through his passion for positive impact on patient health, focused resourcing, innovative marketing strategies, and ethical standards.
Mr. Borgatta said, "I am delighted to join and work with GSK Korea, which continues its impressive growth in vaccines and specialty medicines. We will focus on strengthened access and stable supply of our broad vaccine portfolio and multiple innovative therapies".
[WIKI KOREA=Cho Pil Hyun, Staff Reporter]
chop23@wikileaks-kr.org
